Cargando…
VIM-AS1 promotes proliferation and drives enzalutamide resistance in prostate cancer via IGF2BP2-mediated HMGCS1 mRNA stabilization
VIM-AS1, a cancer-specific long non-coding RNA, has been recognized as a pivotal regulator in multiple types of cancer. However, the role of VIM-AS1 in the proliferation and resistance to anti-androgen therapy of LNCaP and C4-2 prostate cancer cells remains to be determined. In the current study, ga...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
D.A. Spandidos
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9911078/ https://www.ncbi.nlm.nih.gov/pubmed/36734275 http://dx.doi.org/10.3892/ijo.2023.5482 |